Effect of Tourniquet Abstention on Pain Reduction in Venous Sampling in the Elderly People
NO-GARROT
2 other identifiers
interventional
240
1 country
5
Brief Summary
This prospective study evaluates the effect of abstaining from tourniquets on pain reduction during the venous puncture of the elderly people.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 7, 2022
CompletedStudy Start
First participant enrolled
May 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2024
CompletedDecember 31, 2024
December 1, 2024
2.2 years
December 15, 2021
December 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the maximum pain associated with venous puncture, in elderly patients with a visible or palpable vein depending on the method of sampling.
Assessment of maximum pain on examination (including pain from skin-vascular invasion and tourniquet pain)by the patient using a verbal numerical scale (EN) rated from 0 to 10. This measure concerns the 1st sampling as a whole, regardless of the number of attempts necessary to obtain it and their terms
At the end of the study, an average of 12 month
Secondary Outcomes (12)
Proportion of elderly patients with a visible or palpable vein
At the end of the study, an average of 12 month
Comparison of the number of cutaneous-vascular breaks necessary for obtain a blood sample, according to the venous sampling procedure
At the end of the study, an average of 12 month
Comparison of the time taken to obtain a blood sample by caregivers, according to the venous sampling procedures
At the end of the study, an average of 12 month
Comparison of the ease of taking the sample by caregivers, according to the venous sampling procedure
At the end of the study, an average of 12 month
Estimation of the pain due to the tourniquet and to the cutaneous-vascular breaks in patients where sample was taken with tourniquet
At the end of the study, an average of 12 month
- +7 more secondary outcomes
Study Arms (3)
Rubber tourniquet
EXPERIMENTALThe blood sample is taken with a rubber tourniquet,
Fabric tourniquet
EXPERIMENTALThe blood sample is taken with a a fabric tourniquet
No tourniquet
EXPERIMENTALThe blood sample is taken without tourniquet
Interventions
Eligibility Criteria
You may qualify if:
- ≥ 75 years and over,
- Hospitalized in internal medicine or geriatric department,
- For which the 2 upper limbs are accessible to venous puncture (due to the multiple attempts that may be necessary to take a sample during the hospitalization),
- For which at least one vein is visible or palpable on an upper limb,
- Without venous puncture since admission in the department,
- Patient who did not receive a topical anesthetic before the venous puncture (Emla type)
- Communicating patient, able to assess their pain on a digital scale,
- Patients with affiliation to a social security system or beneficiary ,
- Written informed consent (IC) obtained.
You may not qualify if:
- Patient already included,
- Previous pain localized to the upper limbs,
- Hematoma at the planned site of skin-vascular breakage,
- Hemiplegic or quadriplegic patient,
- Patient with lymphedema in the upper limbs,
- Patient with behavioral disorders that may interfere with the proper functioning of the sampling,
- Patient with cognitive impairment preventing understanding of the study and adequate assessment pain (CODEX cognitive score of category C or D),
- Patient placed under legal protection (guardianship).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital NOVOlead
Study Sites (5)
Geriatric Department - CHRU Brest
Brest, 29600, France
Geriatric Department - CH Cholet
Cholet, 49 300, France
Geriatric Department - Hospital Louis Mourier - Colombes
Colombes, 92700, France
Geriatric Department - Intercommunal hospital center - Créteil
Créteil, 94010, France
Geriatric Department - Hospital René Dubos - Pontoise
Pontoise, 95300, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vella QUILLIEN
Hospital René Dubos - Pontoise
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2021
First Posted
February 7, 2022
Study Start
May 18, 2022
Primary Completion
July 11, 2024
Study Completion
July 11, 2024
Last Updated
December 31, 2024
Record last verified: 2024-12